Overview
Huarui Fu practices in Hangzhou, China. Fu is rated as an Experienced expert by MediFind in the treatment of ABO Incompatibility. Their top areas of expertise are Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Graft.
Their clinical research consists of co-authoring 56 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of ABO Incompatibility.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantFu isDistinguished. Learn about Bone Marrow Transplant.
- Advanced
- Graft Versus Host Disease (GvHD)
- LeukemiaFu isAdvanced. Learn about Leukemia.
- Experienced
- ABO IncompatibilityFu isExperienced. Learn about ABO Incompatibility.
- Acute Lymphoblastic Leukemia (ALL)
- Acute Monoblastic Leukemia (AmoL)
- Acute Myeloid Leukemia (AML)
- Adult T-Cell LeukemiaFu isExperienced. Learn about Adult T-Cell Leukemia.
- Bone GraftFu isExperienced. Learn about Bone Graft.